EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Sanofi (SNY) had EBIT Margin of 17.48% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$14.30B |
|
$398.81M |
|
$3.51B |
|
$10.79B |
|
$11.80B |
|
$2.50B |
|
$-1.53B |
|
$973.18M |
|
$2.17B |
|
$448.80M |
|
$438.34M |
|
$438.34M |
|
$2.29B |
|
$2.50B |
|
$2.50B |
|
2.39B |
|
2.39B |
|
$0.17 |
|
$0.17 |
|
| Balance Sheet Financials | |
$36.65B |
|
$12.05B |
|
$113.41B |
|
$150.06B |
|
$37.13B |
|
$17.03B |
|
$32.05B |
|
$69.17B |
|
$80.89B |
|
$1.46B |
|
$80.89B |
|
2.43B |
|
| Cash Flow Statement Financials | |
$5.40B |
|
$-3.07B |
|
$-3.87B |
|
$8.91B |
|
$7.38B |
|
$-1.53B |
|
-- |
|
$-5.75B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.99 |
|
-- |
|
-- |
|
0.17 |
|
0.31 |
|
75.47% |
|
17.48% |
|
|
EBIT Margin |
17.48% |
-- |
|
6.80% |
|
2.79% |
|
$4.38B |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.27 |
|
1.34 |
|
67.36 |
|
0.54% |
|
30.06% |
|
0.29% |
|
0.45% |
|
$33.31 |
|
$1.83 |
|
$2.26 |
|